Synergy between the KEAP1/NRF2 and PI3K Pathways Drives Non-Small-Cell Lung Cancer with an Altered Immune Microenvironment

Journal: Cell Metabolism

Published: 2018-03-08

DOI: 10.1016/j.cmet.2018.02.006

Affiliations: 8

Authors: 11

Go to article
Institutions FC
Department of Medical Biology, UniMelb, Australia 0.21
ACRF Stem Cells and Cancer Division, WEHI, Australia 0.18
Metabolomics Australia, Australia 0.18
Bio21 Molecular Science and Biotechnology Institute (Bio21 Institute), UniMelb, Australia 0.18
Division of Molecular Genetics of Cancer, WEHI, Australia 0.09
St Vincent's Hospital Melbourne, Australia 0.09
Division of Molecular Medicine, WEHI, Australia 0.03
School of Mathematics and Statistics, UniMelb, Australia 0.03